Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy

Y Mimura, T Katoh, R Saldova, R O'Flaherty… - Protein & …, 2018 - academic.oup.com
Glycosylation of the Fc region of IgG has a profound impact on the safety and clinical efficacy
of therapeutic antibodies. While the biantennary complex-type oligosaccharide attached to …

The biology of IGE and the basis of allergic disease

HJ Gould, BJ Sutton, AJ Beavil… - Annual review of …, 2003 - annualreviews.org
Allergic individuals exposed to minute quantities of allergen experience an immediate
response. Immediate hypersensitivity reflects the permanent sensitization of mucosal mast …

Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses

P Bruhns, B Iannascoli, P England… - Blood, The Journal …, 2009 - ashpublications.org
Distinct genes encode 6 human receptors for IgG (hFcγRs), 3 of which have 2 or 3
polymorphic variants. The specificity and affinity of individual hFcγRs for the 4 human IgG …

FcγRIV: a novel FcR with distinct IgG subclass specificity

F Nimmerjahn, P Bruhns, K Horiuchi, JV Ravetch - Immunity, 2005 - cell.com
Mouse IgG subclasses display a hierarchy of in vivo activities, with IgG2a and IgG2b
showing the greatest protective and pathogenic properties. These enhanced activities result …

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond

PM Hogarth, GA Pietersz - Nature reviews Drug discovery, 2012 - nature.com
The direct or indirect targeting of antibody Fc receptors (FcRs) presents unique opportunities
and interesting challenges for the treatment of inflammatory diseases, cancer and infection …

Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G

M Shiroishi, K Tsumoto, K Amano… - Proceedings of the …, 2003 - National Acad Sciences
Ig-like transcript 4 (ILT4)(also known as leukocyte Ig-like receptor 2, CD85d, and LILRB2) is
a cell surface receptor expressed mainly on myelomonocytic cells, whereas ILT2 (also …

Optimized Fc variants

GA Lazar, AJ Chirino, W Dang, JR Desjarlais… - US Patent …, 2008 - Google Patents
2004-11-10 Assigned to XENCOR, INC. reassignment XENCOR, INC. ASSIGNMENT OF
ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DANG, WEI …

Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcγRIIIa

A Okazaki, E Shoji-Hosaka, K Nakamura… - Journal of molecular …, 2004 - Elsevier
Depletion of fucose from human IgG1 oligosaccharide improves its affinity for Fcγ receptor
IIIa (FcγRIIIa). This is the first case where a glycoform modification is shown to improve …

Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells

JO Richards, S Karki, GA Lazar, H Chen, W Dang… - Molecular cancer …, 2008 - AACR
The contribution of Fc-mediated effector functions to the therapeutic efficacy of some
monoclonal antibodies has motivated efforts to enhance interactions with Fcγ receptors …

Optimized FC variants

GA Lazar, W Dang, JR Desjarlais, SB Karki… - US Patent …, 2012 - Google Patents
2005-09-29 Assigned to XENCOR, INC. reassignment XENCOR, INC. ASSIGNMENT OF
ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: HAYES, ROBERT …